ID FBXW7_MOUSE Reviewed; 710 AA. AC Q8VBV4; A2RRI5; D3YUA5; Q8CCS5; Q8VHP4; DT 01-MAR-2004, integrated into UniProtKB/Swiss-Prot. DT 25-APR-2018, sequence version 2. DT 27-MAR-2024, entry version 180. DE RecName: Full=F-box/WD repeat-containing protein 7 {ECO:0000305}; DE AltName: Full=F-box and WD-40 domain-containing protein 7 {ECO:0000312|MGI:MGI:1354695}; DE AltName: Full=F-box protein FBW7 {ECO:0000305}; DE AltName: Full=F-box protein Fbxw6 {ECO:0000303|PubMed:11735228}; DE AltName: Full=F-box-WD40 repeat protein 6 {ECO:0000303|PubMed:11735228}; DE AltName: Full=SEL-10 {ECO:0000303|PubMed:11425854}; GN Name=Fbxw7 {ECO:0000312|MGI:MGI:1354695}; GN Synonyms=Fbw7 {ECO:0000305}, Fbwd6 {ECO:0000312|EMBL:AAL50052.1}, GN Fbxw6 {ECO:0000312|EMBL:AAL40930.1}; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], TISSUE SPECIFICITY, AND INTERACTION WITH RP SKP1 AND CUL1. RC STRAIN=129/Sv; RX PubMed=11735228; DOI=10.1006/geno.2001.6658; RA Maruyama S., Hatakeyama S., Nakayama K., Ishida N., Kawakami K., RA Nakayama K.; RT "Characterization of a mouse gene (Fbxw6) that encodes a homologue of RT Caenorhabditis elegans SEL-10."; RL Genomics 78:214-222(2001). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RA Ilyin G.P.; RL Submitted (OCT-2001) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=C57BL/6J; RX PubMed=19468303; DOI=10.1371/journal.pbio.1000112; RA Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., RA Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., RA Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S., RA Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R., RA Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K., RA Eichler E.E., Ponting C.P.; RT "Lineage-specific biology revealed by a finished genome assembly of the RT mouse."; RL PLoS Biol. 7:E1000112-E1000112(2009). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 386-710. RC STRAIN=C57BL/6J; TISSUE=Olfactory bulb; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [6] RP INTERACTION WITH NOTCH1 NICD. RX PubMed=11425854; DOI=10.1074/jbc.m101343200; RA Gupta-Rossi N., Le Bail O., Gonen H., Brou C., Logeat F., Six E., RA Ciechanover A., Israel A.; RT "Functional interaction between SEL-10, an F-box protein, and the nuclear RT form of activated Notch1 receptor."; RL J. Biol. Chem. 276:34371-34378(2001). RN [7] RP SUBCELLULAR LOCATION, AND INTERACTION WITH NOTCH1 NICD. RX PubMed=11461910; DOI=10.1074/jbc.m103992200; RA Oeberg C., Li J., Pauley A., Wolf E., Gurney M., Lendahl U.; RT "The Notch intracellular domain is ubiquitinated and negatively regulated RT by the mammalian Sel-10 homolog."; RL J. Biol. Chem. 276:35847-35853(2001). RN [8] RP FUNCTION, PATHWAY, AND INTERACTION WITH NFE2L1. RX PubMed=21953459; DOI=10.1074/jbc.m111.253807; RA Biswas M., Phan D., Watanabe M., Chan J.Y.; RT "The Fbw7 tumor suppressor regulates nuclear factor E2-related factor 1 RT transcription factor turnover through proteasome-mediated proteolysis."; RL J. Biol. Chem. 286:39282-39289(2011). RN [9] RP FUNCTION, PATHWAY, AND UBIQUITINATION. RX PubMed=22748924; DOI=10.1016/j.molcel.2012.05.044; RA Duda D.M., Olszewski J.L., Tron A.E., Hammel M., Lambert L.J., RA Waddell M.B., Mittag T., DeCaprio J.A., Schulman B.A.; RT "Structure of a glomulin-RBX1-CUL1 complex: inhibition of a RING E3 ligase RT through masking of its E2-binding surface."; RL Mol. Cell 47:371-382(2012). RN [10] RP FUNCTION, AND DISRUPTION PHENOTYPE. RX PubMed=27238018; DOI=10.1016/j.cell.2016.05.012; RA Zhao X., Hirota T., Han X., Cho H., Chong L.W., Lamia K., Liu S., RA Atkins A.R., Banayo E., Liddle C., Yu R.T., Yates J.R. III, Kay S.A., RA Downes M., Evans R.M.; RT "Circadian amplitude regulation via FBXW7-targeted REV-ERBalpha RT degradation."; RL Cell 165:1644-1657(2016). RN [11] RP FUNCTION, AND DISRUPTION PHENOTYPE. RX PubMed=29149593; DOI=10.1016/j.molcel.2017.10.018; RA Fukushima H., Shimizu K., Watahiki A., Hoshikawa S., Kosho T., Oba D., RA Sakano S., Arakaki M., Yamada A., Nagashima K., Okabe K., Fukumoto S., RA Jimi E., Bigas A., Nakayama K.I., Nakayama K., Aoki Y., Wei W., Inuzuka H.; RT "NOTCH2 Hajdu-Cheney mutations escape SCFFBW7-dependent proteolysis to RT promote osteoporosis."; RL Mol. Cell 68:645-658(2017). CC -!- FUNCTION: Substrate recognition component of a SCF (SKP1-CUL1-F-box CC protein) E3 ubiquitin-protein ligase complex which mediates the CC ubiquitination and subsequent proteasomal degradation of target CC proteins (PubMed:21953459, PubMed:22748924). Recognizes and binds CC phosphorylated sites/phosphodegrons within target proteins and CC thereafter brings them to the SCF complex for ubiquitination CC (PubMed:22748924). Mediates ubiquitination and subsequent degradation CC of CCNE1 and MYC (PubMed:22748924). Identified substrates include CC cyclin-E (CCNE1 or CCNE2), DISC1, JUN, MYC, NOTCH1 released notch CC intracellular domain (NICD), NOTCH2, MCL1, MLST8, RICTOR and probably CC PSEN1 (By similarity). Acts as a negative regulator of JNK signaling by CC binding to phosphorylated JUN and promoting its ubiquitination and CC subsequent degradation (By similarity). SCF(FBXW7) complex mediates the CC ubiquitination and subsequent degradation of NFE2L1 (PubMed:21953459). CC Involved in bone homeostasis and negative regulation of osteoclast CC differentiation (PubMed:29149593). Regulates the amplitude of the CC cyclic expression of hepatic core clock genes and genes involved in CC lipid and glucose metabolism via ubiquitination and proteasomal CC degradation of their transcriptional repressor NR1D1; CDK1-dependent CC phosphorylation of NR1D1 is necessary for SCF(FBXW7)-mediated CC ubiquitination (PubMed:27238018). Also able to promote 'Lys-63'-linked CC ubiquitination in response to DNA damage (By similarity). The CC SCF(FBXW7) complex facilitates double-strand break repair following CC phosphorylation by ATM: phosphorylation promotes localization to sites CC of double-strand breaks and 'Lys-63'-linked ubiquitination of CC phosphorylated XRCC4, enhancing DNA non-homologous end joining (By CC similarity). {ECO:0000250|UniProtKB:Q969H0, CC ECO:0000269|PubMed:21953459, ECO:0000269|PubMed:22748924, CC ECO:0000269|PubMed:27238018, ECO:0000269|PubMed:29149593}. CC -!- PATHWAY: Protein modification; protein ubiquitination. CC {ECO:0000269|PubMed:21953459, ECO:0000269|PubMed:22748924}. CC -!- SUBUNIT: Homodimer; homodimerization plays a role in substrate binding CC and/or ubiquitination and degradation (By similarity). Component of the CC SCF(FBXW7) complex consisting of CUL1, RBX1, SKP1 and FBXW7 CC (PubMed:11735228). Interacts (via F-box domain) with SKP1 CC (PubMed:11735228). Interacts (via F-box domain) with pseudophosphatase CC STYX; the interaction is direct and prevents FBXW7 interaction with CC SKP1 (By similarity). Interacts with cyclin-E (CCNE1 or CCNE2) (By CC similarity). Interacts with PSEN1 (By similarity). Forms a trimeric CC complex with NOTCH1 and SGK1 (By similarity). Interacts with NOTCH1 CC intracellular domain/NICD and NOTCH4 intracellular domain/NICD CC (PubMed:11425854, PubMed:11461910). Interacts with NOTCH2 intracellular CC domain (N2ICD) (By similarity). Interacts with MYC (when CC phosphorylated) (By similarity). Interacts with USP28, counteracting CC ubiquitination of MYC (By similarity). Interacts (when phosphorylated CC at Thr-208) with PIN1, disrupting FBXW7 dimerization and promoting CC FBXW7 autoubiquitination and degradation (By similarity). Interacts CC with UBE2QL1 (By similarity). Interacts with FAM83D; promotes FBXW7 CC degradation (By similarity). Interacts with MYCN; FBXW7 competes with CC AURKA for binding to unphosphorylated MYCN but not for binding to CC phosphorylated MYCN (By similarity). Interacts with JUN (By CC similarity). Found in a complex with JUN and PRR7 (By similarity). CC Interacts with JUN and PRR7; the interaction inhibits ubiquitination- CC mediated JUN degradation, promoting its phosphorylation and CC transcriptional activity (By similarity). Interacts with NFE2L1 CC (PubMed:21953459). Interacts with NR1D1 (By similarity). Interacts with CC RICTOR; mediates RICTOR ubiquitination and degradation (By similarity). CC Interacts with USP38, counteracting ubiquitination of MYC (By CC similarity). {ECO:0000250|UniProtKB:Q969H0, CC ECO:0000269|PubMed:11425854, ECO:0000269|PubMed:11461910, CC ECO:0000269|PubMed:11735228, ECO:0000269|PubMed:21953459}. CC -!- SUBCELLULAR LOCATION: Nucleus, nucleoplasm CC {ECO:0000269|PubMed:11461910}. Chromosome CC {ECO:0000250|UniProtKB:Q969H0}. Note=Localizes to site of double-strand CC breaks following phosphorylation by ATM. CC {ECO:0000250|UniProtKB:Q969H0}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q8VBV4-2; Sequence=Displayed; CC Name=2; CC IsoId=Q8VBV4-1; Sequence=VSP_059530; CC -!- TISSUE SPECIFICITY: Widely expressed with highest levels in brain, CC heart and testis. {ECO:0000269|PubMed:11735228}. CC -!- DOMAIN: The WD repeats mediate interaction with substrates of the SCF CC (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex. CC {ECO:0000250|UniProtKB:Q969H0}. CC -!- DOMAIN: The F-box domain mediates interaction with SKP1. CC {ECO:0000250|UniProtKB:Q969H0}. CC -!- PTM: Phosphorylation at Thr-208 promotes interaction with PIN1, leading CC to disrupt FBXW7 dimerization and promoting FBXW7 autoubiquitination CC and degradation. Phosphorylated by ATM at Ser-26 in response to DNA CC damage, promoting recruitment to DNA damage sites and 'Lys-63'-linked CC ubiquitination of phosphorylated XRCC4. {ECO:0000250|UniProtKB:Q969H0}. CC -!- PTM: Ubiquitinated: autoubiquitinates following phosphorylation at Thr- CC 208 and subsequent interaction with PIN1 (By similarity). CC Ubiquitination leads to its proteasomal degradation (PubMed:22748924). CC {ECO:0000250|UniProtKB:Q969H0, ECO:0000269|PubMed:22748924}. CC -!- DISRUPTION PHENOTYPE: Whole body FBW7 knockout is embryonic lethal. CC Conditional knockout mice in which FBW7 expression is specifically CC abolished in osteoclasts display severe bone resorption, bone fragility CC and low bone mass (PubMed:29149593). Conditional knockout in liver CC reduces the amplitude of the diurnal expression of many core clock CC genes and the altered expression of a large number of genes controlling CC liver metabolic pathways (PubMed:27238018). CC {ECO:0000269|PubMed:27238018, ECO:0000269|PubMed:29149593}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF391202; AAL40930.1; -; Genomic_DNA. DR EMBL; AF391193; AAL40930.1; JOINED; Genomic_DNA. DR EMBL; AF391194; AAL40930.1; JOINED; Genomic_DNA. DR EMBL; AF391195; AAL40930.1; JOINED; Genomic_DNA. DR EMBL; AF391196; AAL40930.1; JOINED; Genomic_DNA. DR EMBL; AF391197; AAL40930.1; JOINED; Genomic_DNA. DR EMBL; AF391198; AAL40930.1; JOINED; Genomic_DNA. DR EMBL; AF391199; AAL40930.1; JOINED; Genomic_DNA. DR EMBL; AF391200; AAL40930.1; JOINED; Genomic_DNA. DR EMBL; AF391201; AAL40930.1; JOINED; Genomic_DNA. DR EMBL; AF391192; AAL40928.1; -; mRNA. DR EMBL; AF427101; AAL50052.1; -; mRNA. DR EMBL; AC124496; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC158583; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC131648; AAI31649.1; -; mRNA. DR EMBL; AK032174; BAC27743.1; -; mRNA. DR CCDS; CCDS17440.1; -. [Q8VBV4-1] DR CCDS; CCDS50940.1; -. [Q8VBV4-2] DR RefSeq; NP_001171244.1; NM_001177773.1. [Q8VBV4-2] DR RefSeq; NP_001171245.1; NM_001177774.1. [Q8VBV4-2] DR RefSeq; NP_536353.2; NM_080428.3. [Q8VBV4-1] DR RefSeq; XP_006501719.1; XM_006501656.3. [Q8VBV4-2] DR RefSeq; XP_006501720.1; XM_006501657.3. [Q8VBV4-2] DR AlphaFoldDB; Q8VBV4; -. DR SMR; Q8VBV4; -. DR BioGRID; 206088; 56. DR DIP; DIP-61083N; -. DR IntAct; Q8VBV4; 3. DR MINT; Q8VBV4; -. DR STRING; 10090.ENSMUSP00000103306; -. DR iPTMnet; Q8VBV4; -. DR PhosphoSitePlus; Q8VBV4; -. DR jPOST; Q8VBV4; -. DR PaxDb; 10090-ENSMUSP00000103306; -. DR ProteomicsDB; 271558; -. [Q8VBV4-2] DR ProteomicsDB; 332538; -. DR Antibodypedia; 27779; 777 antibodies from 36 providers. DR DNASU; 50754; -. DR Ensembl; ENSMUST00000029727.8; ENSMUSP00000029727.8; ENSMUSG00000028086.16. [Q8VBV4-1] DR Ensembl; ENSMUST00000107678.8; ENSMUSP00000103305.2; ENSMUSG00000028086.16. [Q8VBV4-2] DR Ensembl; ENSMUST00000107679.8; ENSMUSP00000103306.2; ENSMUSG00000028086.16. [Q8VBV4-2] DR GeneID; 50754; -. DR KEGG; mmu:50754; -. DR UCSC; uc008pqk.2; mouse. DR UCSC; uc008pql.2; mouse. [Q8VBV4-2] DR AGR; MGI:1354695; -. DR CTD; 55294; -. DR MGI; MGI:1354695; Fbxw7. DR VEuPathDB; HostDB:ENSMUSG00000028086; -. DR eggNOG; KOG0274; Eukaryota. DR GeneTree; ENSGT00940000154986; -. DR InParanoid; Q8VBV4; -. DR OrthoDB; 587035at2759; -. DR PhylomeDB; Q8VBV4; -. DR TreeFam; TF101074; -. DR Reactome; R-MMU-8951664; Neddylation. DR Reactome; R-MMU-983168; Antigen processing: Ubiquitination & Proteasome degradation. DR UniPathway; UPA00143; -. DR BioGRID-ORCS; 50754; 6 hits in 81 CRISPR screens. DR ChiTaRS; Fbxw7; mouse. DR PRO; PR:Q8VBV4; -. DR Proteomes; UP000000589; Chromosome 3. DR RNAct; Q8VBV4; Protein. DR Bgee; ENSMUSG00000028086; Expressed in retrosplenial region and 254 other cell types or tissues. DR ExpressionAtlas; Q8VBV4; baseline and differential. DR GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell. DR GO; GO:0005737; C:cytoplasm; ISO:MGI. DR GO; GO:0005829; C:cytosol; TAS:Reactome. DR GO; GO:0005783; C:endoplasmic reticulum; IDA:MGI. DR GO; GO:0005794; C:Golgi apparatus; IDA:MGI. DR GO; GO:0016020; C:membrane; NAS:ParkinsonsUK-UCL. DR GO; GO:0005739; C:mitochondrion; IDA:ParkinsonsUK-UCL. DR GO; GO:0005730; C:nucleolus; IDA:MGI. DR GO; GO:0005654; C:nucleoplasm; ISO:MGI. DR GO; GO:0005634; C:nucleus; IDA:BHF-UCL. DR GO; GO:1990452; C:Parkin-FBXW7-Cul1 ubiquitin ligase complex; ISS:ParkinsonsUK-UCL. DR GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL. DR GO; GO:0032991; C:protein-containing complex; ISO:MGI. DR GO; GO:0019005; C:SCF ubiquitin ligase complex; ISS:UniProtKB. DR GO; GO:0030332; F:cyclin binding; ISS:ParkinsonsUK-UCL. DR GO; GO:0042802; F:identical protein binding; ISO:MGI. DR GO; GO:0050816; F:phosphothreonine residue binding; ISS:UniProtKB. DR GO; GO:0030674; F:protein-macromolecule adaptor activity; ISS:ParkinsonsUK-UCL. DR GO; GO:0043130; F:ubiquitin binding; IBA:GO_Central. DR GO; GO:1990756; F:ubiquitin ligase-substrate adaptor activity; ISS:UniProtKB. DR GO; GO:0061630; F:ubiquitin protein ligase activity; TAS:Reactome. DR GO; GO:0031625; F:ubiquitin protein ligase binding; ISS:ParkinsonsUK-UCL. DR GO; GO:0097027; F:ubiquitin-protein transferase activator activity; ISS:ParkinsonsUK-UCL. DR GO; GO:0034644; P:cellular response to UV; ISS:ParkinsonsUK-UCL. DR GO; GO:0006974; P:DNA damage response; ISS:UniProtKB. DR GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW. DR GO; GO:0030324; P:lung development; IMP:MGI. DR GO; GO:0010629; P:negative regulation of gene expression; ISO:MGI. DR GO; GO:2001205; P:negative regulation of osteoclast development; IMP:UniProtKB. DR GO; GO:0007219; P:Notch signaling pathway; IDA:MGI. DR GO; GO:0045741; P:positive regulation of epidermal growth factor-activated receptor activity; ISS:ParkinsonsUK-UCL. DR GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:ParkinsonsUK-UCL. DR GO; GO:1903378; P:positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; IMP:ParkinsonsUK-UCL. DR GO; GO:1901800; P:positive regulation of proteasomal protein catabolic process; IMP:ParkinsonsUK-UCL. DR GO; GO:1903955; P:positive regulation of protein targeting to mitochondrion; ISO:MGI. DR GO; GO:0031398; P:positive regulation of protein ubiquitination; ISS:ParkinsonsUK-UCL. DR GO; GO:2000060; P:positive regulation of ubiquitin-dependent protein catabolic process; IMP:UniProtKB. DR GO; GO:0051443; P:positive regulation of ubiquitin-protein transferase activity; ISS:ParkinsonsUK-UCL. DR GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISO:MGI. DR GO; GO:0031648; P:protein destabilization; IDA:MGI. DR GO; GO:0070534; P:protein K63-linked ubiquitination; ISS:UniProtKB. DR GO; GO:0050821; P:protein stabilization; ISS:ParkinsonsUK-UCL. DR GO; GO:0016567; P:protein ubiquitination; ISS:UniProtKB. DR GO; GO:1903146; P:regulation of autophagy of mitochondrion; ISO:MGI. DR GO; GO:0090049; P:regulation of cell migration involved in sprouting angiogenesis; IMP:CACAO. DR GO; GO:0042752; P:regulation of circadian rhythm; IMP:UniProtKB. DR GO; GO:1901524; P:regulation of mitophagy; IEA:Ensembl. DR GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW. DR GO; GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB. DR GO; GO:0007062; P:sister chromatid cohesion; ISS:ParkinsonsUK-UCL. DR GO; GO:0010992; P:ubiquitin recycling; IBA:GO_Central. DR GO; GO:0001570; P:vasculogenesis; IMP:MGI. DR CDD; cd22133; F-box_FBXW7; 1. DR CDD; cd00200; WD40; 1. DR Gene3D; 1.20.1280.50; -; 1. DR Gene3D; 2.130.10.10; YVTN repeat-like/Quinoprotein amine dehydrogenase; 1. DR InterPro; IPR036047; F-box-like_dom_sf. DR InterPro; IPR001810; F-box_dom. DR InterPro; IPR020472; G-protein_beta_WD-40_rep. DR InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf. DR InterPro; IPR019775; WD40_repeat_CS. DR InterPro; IPR036322; WD40_repeat_dom_sf. DR InterPro; IPR001680; WD40_rpt. DR PANTHER; PTHR19849:SF1; F-BOX_WD REPEAT-CONTAINING PROTEIN 7; 1. DR PANTHER; PTHR19849; PHOSPHOLIPASE A-2-ACTIVATING PROTEIN; 1. DR Pfam; PF12937; F-box-like; 1. DR Pfam; PF00400; WD40; 7. DR PRINTS; PR00320; GPROTEINBRPT. DR SMART; SM00256; FBOX; 1. DR SMART; SM00320; WD40; 8. DR SUPFAM; SSF81383; F-box domain; 1. DR SUPFAM; SSF50978; WD40 repeat-like; 1. DR PROSITE; PS50181; FBOX; 1. DR PROSITE; PS00678; WD_REPEATS_1; 5. DR PROSITE; PS50082; WD_REPEATS_2; 7. DR PROSITE; PS50294; WD_REPEATS_REGION; 1. DR Genevisible; Q8VBV4; MM. PE 1: Evidence at protein level; KW Alternative splicing; Biological rhythms; Chromosome; DNA damage; KW DNA repair; Nucleus; Phosphoprotein; Reference proteome; Repeat; KW Ubl conjugation; Ubl conjugation pathway; WD repeat. FT CHAIN 1..710 FT /note="F-box/WD repeat-containing protein 7" FT /id="PRO_0000050995" FT DOMAIN 281..327 FT /note="F-box" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00080" FT REPEAT 381..421 FT /note="WD 1" FT REPEAT 423..459 FT /note="WD 2" FT REPEAT 462..501 FT /note="WD 3" FT REPEAT 503..539 FT /note="WD 4" FT REPEAT 542..581 FT /note="WD 5" FT REPEAT 583..621 FT /note="WD 6" FT REPEAT 625..662 FT /note="WD 7" FT REGION 1..158 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 17..32 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 33..56 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 66..91 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 92..133 FT /note="Acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 144..158 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 26 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q969H0" FT MOD_RES 208 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q969H0" FT MOD_RES 230 FT /note="Phosphoserine; by SGK1" FT /evidence="ECO:0000250|UniProtKB:Q969H0" FT VAR_SEQ 1..169 FT /note="MNQELLSVGSKRRRTGGSLRGNASSSQVDEGQMNRVVEEDPQQQARHQEEEH FT TARNGELVGANPRPGDQNDTQQGQVEENNNRFISVDEDSSGNQEEQEEDEEHAGEQEEE FT EEEEEEEEEMDQESDDFDPSDDSSREDEHTHNSNVTNCSSVSDLPAHQLSSPFYTKTT FT -> MRVCVPSSVLVLSCVCWCWGVLLPVPLPNLPFLACLSMSTLESVTYLPEKGLYCQR FT LPSSRTHGGTESLKGKNTENMGFYGTLKMIFY (in isoform 2)" FT /id="VSP_059530" FT CONFLICT 73 FT /note="Q -> R (in Ref. 2; AAL50052)" FT /evidence="ECO:0000305" FT CONFLICT 621 FT /note="Q -> E (in Ref. 2; AAL50052)" FT /evidence="ECO:0000305" FT CONFLICT 700 FT /note="L -> F (in Ref. 2; AAL50052)" FT /evidence="ECO:0000305" FT CONFLICT 705 FT /note="F -> V (in Ref. 2; AAL50052)" FT /evidence="ECO:0000305" SQ SEQUENCE 710 AA; 79848 MW; 9D56F7E81E6E390B CRC64; MNQELLSVGS KRRRTGGSLR GNASSSQVDE GQMNRVVEED PQQQARHQEE EHTARNGELV GANPRPGDQN DTQQGQVEEN NNRFISVDED SSGNQEEQEE DEEHAGEQEE EEEEEEEEEE MDQESDDFDP SDDSSREDEH THNSNVTNCS SVSDLPAHQL SSPFYTKTTK MKRKLDHGSE VRSFSLGKKP CKVSDYTSTT GLVPCSATPT TFGDLRAANG QGQQRRRITS VQPPTGLQEW LKMFQSWSGP EKLLALDELI DSCEPTQVKH MMQVIEPQFQ RDFISLLPKE LALYVLSFLE PKDLLQAAQT CRYWRILAED NLLWREKCKE EGIDEPLHIK RRKIIKPGFI HSPWKSAYIR QHRIDTNWRR GELKSPKVLK GHDDHVITCL QFCGNRIVSG SDDNTLKVWS AVTGKCLRTL VGHTGGVWSS QMRDNIIISG STDRTLKVWN AETGECIHTL YGHTSTVRCM HLHEKRVVSG SRDATLRVWD IETGQCLHVL MGHVAAVRCV QYDGRRVVSG AYDFMVKVWD PETETCLHTL QGHTNRVYSL QFDGIHVVSG SLDTSIRVWD VETGNCIHTL TGHQSLTSGM ELKDNILVSG NADSTVKIWD IKTGQCLQTL QGPSKHQSAV TCLQFNKNFV ITSSDDGTVK LWDLKTGEFI RNLVTLESGG SGGVVWRIRA SNTKLVCAVG SRNGTEETKL LVLDFDVDMK //